Alnylam Pharmaceuticals, Inc. (ALNY)
397.55
-15.08
(-3.65%)
USD |
NASDAQ |
Dec 12, 16:00
397.41
-0.14
(-0.04%)
After-Hours: 20:00
Alnylam Pharmaceuticals Accounts Payable (Quarterly): 117.59M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Pfizer Inc. | 5.024B |
| Bristol Myers Squibb Co. | 4.288B |
| BridgeBio Pharma, Inc. | 18.70M |
| Amgen, Inc. | 2.838B |
| Vertex Pharmaceuticals, Inc. | 420.30M |